. "B5. Use of Antiprogestins Before 63 Days of Amenorrhea." Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press, 1993.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda
pretreatment with naproxen. A double-blind randomized study. Contraception 45:221–227, 1992.
Rådestad, A., Bygdeman, M., and Green, K. Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant uterine cervix in the first trimester. A double-blind, randomized biomechanical and biochemical study. Contraception 41:283–292, 1990.
Silvestre, L., Peyron, R., and Ulmann, A. Sequential treatment with an antiprogestin (mifepristone, RU 486) and a prostaglandin analogue for termination of pregnancy. Abstract, VIIIth World Congress in Human Reproduction, Bali, p. 43, April 4–9, 1993.
Smith, S.K., and Kelly, R.W. The effect of the antiprogestin RU 486 and ZK 98,734 on the synthesis and metabolism of prostaglandins F 2a and E2 in separated cells from early human decidua. Journal of Clinical Endocrinology and Metabolism 65:527–534, 1987.
Swahn, M.L., and Bygdeman, M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. British Journal of Obstetrics and Gynaecology 95:126–134, 1988.
Swahn, M.L., Gottlieb, C., Green, K., et al. Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy. Contraception 41:461–473, 1990.
U.K. Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. British Journal of Obstetrics and Gynaecology 97:480–486, 1990.
Ulmann, A., Silvestre, L., Chemama, L., et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Acta Obstetricia et Gynecologica Scandinavica (Umea) 71:278–283, 1992.
Van Look, P.F., and Bygdeman, M. Antiprogestational steroids: A new dimension in human fertility regulation. Oxford Reviews of Reproductive Biology 11:2–60, 1989.
World Health Organization (WHO), Task Force on Postovulatory Methods for Fertility Regulation. The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. British Journal of Obstetrics and Gynaecology 97:260–266, 1990.
World Health Organization (WHO), Task Force on Postovulatory Methods for Fertility Regulation. Pregnancy termination with mifepristone and gemeprost: a Multicenter comparison between repeated doses and a single dose of mifepristone. Fertility and Sterility 56:32–40, 1991.